Benjamin F. Edwards & Company, Inc. Amarin Corp Plcuk Transaction History

Benjamin F. Edwards & Company, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 07, 2020	SELL	$4.0 - $21.53 $8,300 - $44,674	-2,075 Closed	0 $0
Q3 2019 Nov 05, 2019	SELL	$13.89 - $23.16 $10,070 - $16,791	-725 Reduced 25.89%	2,075 $31,000
Q1 2019 May 15, 2019	BUY	$12.61 - $22.33 $3,783 - $6,698	300 Added 12.0%	2,800 $58,000
Q4 2018 Jan 31, 2019	BUY	$12.41 - $22.98 $31,025 - $57,450	2,500 New	2,500 $34,000
Q2 2018 Jul 19, 2018	SELL	$2.68 - $3.48 $1,072 - $1,392	-400 Closed	0 $0
Q3 2017 Oct 24, 2017	BUY	$3.03 - $3.72 $1,212 - $1,488	400	400 $1,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $222M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Benjamin F. Edwards & Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Benjamin F. Edwards & Company, Inc. with notifications on news.